Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Meningococcal Vaccine market report explains the definition, types, applications, major countries, and major players of the Meningococcal Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Baxter
CSL
Novartis
Bio-Med
Serum Institute of India
Zhifei
JN International Medical Corporation
China National Biotec Group
GSK
Walvax
Merck
Hualan Bio
By Type:
Quadrivalent
Bivalent
Others
By End-User:
Pneumonia
Meningitis
Bacteremia
Others (Arthritis
Conjunctivitis
Urethritis)
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Meningococcal Vaccine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Meningococcal Vaccine Outlook to 2028- Original Forecasts
-
2.2 Meningococcal Vaccine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Meningococcal Vaccine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Meningococcal Vaccine Market- Recent Developments
-
6.1 Meningococcal Vaccine Market News and Developments
-
6.2 Meningococcal Vaccine Market Deals Landscape
7 Meningococcal Vaccine Raw Materials and Cost Structure Analysis
-
7.1 Meningococcal Vaccine Key Raw Materials
-
7.2 Meningococcal Vaccine Price Trend of Key Raw Materials
-
7.3 Meningococcal Vaccine Key Suppliers of Raw Materials
-
7.4 Meningococcal Vaccine Market Concentration Rate of Raw Materials
-
7.5 Meningococcal Vaccine Cost Structure Analysis
-
7.5.1 Meningococcal Vaccine Raw Materials Analysis
-
7.5.2 Meningococcal Vaccine Labor Cost Analysis
-
7.5.3 Meningococcal Vaccine Manufacturing Expenses Analysis
8 Global Meningococcal Vaccine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Meningococcal Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Meningococcal Vaccine Export by Region (Top 10 Countries) (2017-2028)
9 Global Meningococcal Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Meningococcal Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Quadrivalent Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bivalent Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Meningococcal Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pneumonia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Meningitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bacteremia Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others (Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Conjunctivitis Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Urethritis) Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Meningococcal Vaccine Market Analysis and Outlook till 2022
-
10.1 Global Meningococcal Vaccine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Meningococcal Vaccine Consumption (2017-2022)
-
10.2.2 Canada Meningococcal Vaccine Consumption (2017-2022)
-
10.2.3 Mexico Meningococcal Vaccine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Meningococcal Vaccine Consumption (2017-2022)
-
10.3.2 UK Meningococcal Vaccine Consumption (2017-2022)
-
10.3.3 Spain Meningococcal Vaccine Consumption (2017-2022)
-
10.3.4 Belgium Meningococcal Vaccine Consumption (2017-2022)
-
10.3.5 France Meningococcal Vaccine Consumption (2017-2022)
-
10.3.6 Italy Meningococcal Vaccine Consumption (2017-2022)
-
10.3.7 Denmark Meningococcal Vaccine Consumption (2017-2022)
-
10.3.8 Finland Meningococcal Vaccine Consumption (2017-2022)
-
10.3.9 Norway Meningococcal Vaccine Consumption (2017-2022)
-
10.3.10 Sweden Meningococcal Vaccine Consumption (2017-2022)
-
10.3.11 Poland Meningococcal Vaccine Consumption (2017-2022)
-
10.3.12 Russia Meningococcal Vaccine Consumption (2017-2022)
-
10.3.13 Turkey Meningococcal Vaccine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Meningococcal Vaccine Consumption (2017-2022)
-
10.4.2 Japan Meningococcal Vaccine Consumption (2017-2022)
-
10.4.3 India Meningococcal Vaccine Consumption (2017-2022)
-
10.4.4 South Korea Meningococcal Vaccine Consumption (2017-2022)
-
10.4.5 Pakistan Meningococcal Vaccine Consumption (2017-2022)
-
10.4.6 Bangladesh Meningococcal Vaccine Consumption (2017-2022)
-
10.4.7 Indonesia Meningococcal Vaccine Consumption (2017-2022)
-
10.4.8 Thailand Meningococcal Vaccine Consumption (2017-2022)
-
10.4.9 Singapore Meningococcal Vaccine Consumption (2017-2022)
-
10.4.10 Malaysia Meningococcal Vaccine Consumption (2017-2022)
-
10.4.11 Philippines Meningococcal Vaccine Consumption (2017-2022)
-
10.4.12 Vietnam Meningococcal Vaccine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Meningococcal Vaccine Consumption (2017-2022)
-
10.5.2 Colombia Meningococcal Vaccine Consumption (2017-2022)
-
10.5.3 Chile Meningococcal Vaccine Consumption (2017-2022)
-
10.5.4 Argentina Meningococcal Vaccine Consumption (2017-2022)
-
10.5.5 Venezuela Meningococcal Vaccine Consumption (2017-2022)
-
10.5.6 Peru Meningococcal Vaccine Consumption (2017-2022)
-
10.5.7 Puerto Rico Meningococcal Vaccine Consumption (2017-2022)
-
10.5.8 Ecuador Meningococcal Vaccine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Meningococcal Vaccine Consumption (2017-2022)
-
10.6.2 Kuwait Meningococcal Vaccine Consumption (2017-2022)
-
10.6.3 Oman Meningococcal Vaccine Consumption (2017-2022)
-
10.6.4 Qatar Meningococcal Vaccine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Meningococcal Vaccine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Meningococcal Vaccine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Meningococcal Vaccine Consumption (2017-2022)
-
10.7.2 South Africa Meningococcal Vaccine Consumption (2017-2022)
-
10.7.3 Egypt Meningococcal Vaccine Consumption (2017-2022)
-
10.7.4 Algeria Meningococcal Vaccine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Meningococcal Vaccine Consumption (2017-2022)
-
10.8.2 New Zealand Meningococcal Vaccine Consumption (2017-2022)
11 Global Meningococcal Vaccine Competitive Analysis
-
11.1 Baxter
-
11.1.1 Baxter Company Details
-
11.1.2 Baxter Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Baxter Meningococcal Vaccine Main Business and Markets Served
-
11.1.4 Baxter Meningococcal Vaccine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 CSL
-
11.2.1 CSL Company Details
-
11.2.2 CSL Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 CSL Meningococcal Vaccine Main Business and Markets Served
-
11.2.4 CSL Meningococcal Vaccine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novartis
-
11.3.1 Novartis Company Details
-
11.3.2 Novartis Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novartis Meningococcal Vaccine Main Business and Markets Served
-
11.3.4 Novartis Meningococcal Vaccine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bio-Med
-
11.4.1 Bio-Med Company Details
-
11.4.2 Bio-Med Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bio-Med Meningococcal Vaccine Main Business and Markets Served
-
11.4.4 Bio-Med Meningococcal Vaccine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Serum Institute of India
-
11.5.1 Serum Institute of India Company Details
-
11.5.2 Serum Institute of India Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Serum Institute of India Meningococcal Vaccine Main Business and Markets Served
-
11.5.4 Serum Institute of India Meningococcal Vaccine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Zhifei
-
11.6.1 Zhifei Company Details
-
11.6.2 Zhifei Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Zhifei Meningococcal Vaccine Main Business and Markets Served
-
11.6.4 Zhifei Meningococcal Vaccine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 JN International Medical Corporation
-
11.7.1 JN International Medical Corporation Company Details
-
11.7.2 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 JN International Medical Corporation Meningococcal Vaccine Main Business and Markets Served
-
11.7.4 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 China National Biotec Group
-
11.8.1 China National Biotec Group Company Details
-
11.8.2 China National Biotec Group Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 China National Biotec Group Meningococcal Vaccine Main Business and Markets Served
-
11.8.4 China National Biotec Group Meningococcal Vaccine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GSK
-
11.9.1 GSK Company Details
-
11.9.2 GSK Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GSK Meningococcal Vaccine Main Business and Markets Served
-
11.9.4 GSK Meningococcal Vaccine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Walvax
-
11.10.1 Walvax Company Details
-
11.10.2 Walvax Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Walvax Meningococcal Vaccine Main Business and Markets Served
-
11.10.4 Walvax Meningococcal Vaccine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Merck
-
11.11.1 Merck Company Details
-
11.11.2 Merck Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Merck Meningococcal Vaccine Main Business and Markets Served
-
11.11.4 Merck Meningococcal Vaccine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Hualan Bio
-
11.12.1 Hualan Bio Company Details
-
11.12.2 Hualan Bio Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Hualan Bio Meningococcal Vaccine Main Business and Markets Served
-
11.12.4 Hualan Bio Meningococcal Vaccine Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Meningococcal Vaccine Market Outlook by Types and Applications to 2028
-
12.1 Global Meningococcal Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Quadrivalent Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Bivalent Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Meningococcal Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Meningitis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Bacteremia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others (Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Conjunctivitis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Urethritis) Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Meningococcal Vaccine Market Analysis and Outlook to 2028
-
13.1 Global Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.2.2 Canada Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.2 UK Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.3 Spain Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.5 France Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.6 Italy Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.8 Finland Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.9 Norway Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.11 Poland Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.12 Russia Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.2 Japan Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.3 India Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.3 Chile Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.6 Peru Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.6.3 Oman Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Meningococcal Vaccine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Meningococcal Vaccine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Meningococcal Vaccine
-
Figure of Meningococcal Vaccine Picture
-
Table Global Meningococcal Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Meningococcal Vaccine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Quadrivalent Consumption and Growth Rate (2017-2022)
-
Figure Global Bivalent Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumonia Consumption and Growth Rate (2017-2022)
-
Figure Global Meningitis Consumption and Growth Rate (2017-2022)
-
Figure Global Bacteremia Consumption and Growth Rate (2017-2022)
-
Figure Global Others (Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Conjunctivitis Consumption and Growth Rate (2017-2022)
-
Figure Global Urethritis) Consumption and Growth Rate (2017-2022)
-
Figure Global Meningococcal Vaccine Consumption by Country (2017-2022)
-
Table North America Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure United States Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Canada Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure Germany Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure UK Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Spain Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure France Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Italy Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Finland Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Norway Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Poland Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Russia Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table APAC Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure China Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table South America Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure Brazil Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Chile Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Peru Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table GCC Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure Bahrain Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Oman Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table Africa Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure Nigeria Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table Oceania Meningococcal Vaccine Consumption by Country (2017-2022)
-
Figure Australia Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Meningococcal Vaccine Consumption and Growth Rate (2017-2022)
-
Table Baxter Company Details
-
Table Baxter Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Meningococcal Vaccine Main Business and Markets Served
-
Table Baxter Meningococcal Vaccine Product Portfolio
-
Table CSL Company Details
-
Table CSL Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Meningococcal Vaccine Main Business and Markets Served
-
Table CSL Meningococcal Vaccine Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Meningococcal Vaccine Main Business and Markets Served
-
Table Novartis Meningococcal Vaccine Product Portfolio
-
Table Bio-Med Company Details
-
Table Bio-Med Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Med Meningococcal Vaccine Main Business and Markets Served
-
Table Bio-Med Meningococcal Vaccine Product Portfolio
-
Table Serum Institute of India Company Details
-
Table Serum Institute of India Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Meningococcal Vaccine Main Business and Markets Served
-
Table Serum Institute of India Meningococcal Vaccine Product Portfolio
-
Table Zhifei Company Details
-
Table Zhifei Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhifei Meningococcal Vaccine Main Business and Markets Served
-
Table Zhifei Meningococcal Vaccine Product Portfolio
-
Table JN International Medical Corporation Company Details
-
Table JN International Medical Corporation Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table JN International Medical Corporation Meningococcal Vaccine Main Business and Markets Served
-
Table JN International Medical Corporation Meningococcal Vaccine Product Portfolio
-
Table China National Biotec Group Company Details
-
Table China National Biotec Group Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table China National Biotec Group Meningococcal Vaccine Main Business and Markets Served
-
Table China National Biotec Group Meningococcal Vaccine Product Portfolio
-
Table GSK Company Details
-
Table GSK Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Meningococcal Vaccine Main Business and Markets Served
-
Table GSK Meningococcal Vaccine Product Portfolio
-
Table Walvax Company Details
-
Table Walvax Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Walvax Meningococcal Vaccine Main Business and Markets Served
-
Table Walvax Meningococcal Vaccine Product Portfolio
-
Table Merck Company Details
-
Table Merck Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Meningococcal Vaccine Main Business and Markets Served
-
Table Merck Meningococcal Vaccine Product Portfolio
-
Table Hualan Bio Company Details
-
Table Hualan Bio Meningococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Bio Meningococcal Vaccine Main Business and Markets Served
-
Table Hualan Bio Meningococcal Vaccine Product Portfolio
-
Figure Global Quadrivalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bivalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meningitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bacteremia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others (Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Conjunctivitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urethritis) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Table North America Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Germany Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure China Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Meningococcal Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Australia Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Meningococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
